Your browser doesn't support javascript.
loading
Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer.
Schmitz-Dräger, Bernd J; Todenhöfer, Tilman; van Rhijn, Bas; Pesch, Beate; Hudson, Mliss A; Chandra, Ashish; Ingersoll, Molly A; Kassouf, Wassim; Palou, Joan; Taylor, John; Vlahou, Antonia; Behrens, Thomas; Critelli, Rossana; Grossman, H Barton; Sanchez-Carbayo, Marta; Kamat, Ashish.
Affiliation
  • Schmitz-Dräger BJ; Urologie24, Fürth, Germany; Schön Klinik Nürnberg/Fürth, Fürth, Germany. Electronic address: bernd_sd@yahoo.de.
  • Todenhöfer T; Urologische Universitätsklinik, Eberhard Karls Universität, Tübingen, Germany.
  • van Rhijn B; Division of Surgical Oncology (Urology), Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Pesch B; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr University, Bochum, Germany.
  • Hudson MA; Ochsner Clinic Foundation, Tom and Gayle Benson Cancer Center, New Orleans, LA.
  • Chandra A; Cellular Pathology, St Thomas' Hospital, London, UK.
  • Ingersoll MA; Department of Immunology, Institute Pasteur and U818 Inserm, Paris, France.
  • Kassouf W; McGill University Health Center, Montreal, Canada.
  • Palou J; Servicio de Urología, Fundación Puigvert, Barcelona, Spain.
  • Taylor J; Division of Urology, University of Connecticut Health Center, Farmington, CT.
  • Vlahou A; Division of Biotechnology, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
  • Behrens T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr University, Bochum, Germany; Protein Research Unit Ruhr within Europe (PURE), Ruhr-Universität, Bochum, Germany.
  • Critelli R; Department of Genetics, Biology and Biochemistry, Universita di Torino, Torino, Italy; HuGeF-Human Genetics Foundation, Torino, Italy.
  • Grossman HB; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sanchez-Carbayo M; CIC bioGUNE, Bilbao, Spain.
  • Kamat A; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX.
Urol Oncol ; 32(7): 1061-8, 2014 Oct.
Article in En | MEDLINE | ID: mdl-24411790
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Urol Oncol Journal subject: NEOPLASIAS / UROLOGIA Year: 2014 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Urol Oncol Journal subject: NEOPLASIAS / UROLOGIA Year: 2014 Document type: Article Country of publication: United States